Skip to content
Institutional Investor growth pre-IPO Est. 2014

Cell Innovation Partners

Life sciences sector focused VC firm investing in geographies such as Australia, Belgium and Taiwan

📍 Yokohama, Japan

About This Fund

Cell Innovation Partners is a venture capital firm. Geographies of interest include Australia, Belgium, and Taiwan. Typically invests in life sciences sectors such as Biopharma and Biotech. Notable portfolio companies include Promethera, Elastagen, Steminent Biotherapeutics.

Investment Focus

Sectors
stem cell iPS cells regenerative medicine cell therapy
Stages
growth pre-IPO
Check Size $0.5M-$1M
Geography
USA Japan

What They Look For

bio-ventures developing pluripotent/iPS cells and regenerative medicine technologies with high growth potential expected to enter business phase in 5-7 years; geography: Japan, US, EU

Preparing to pitch Cell Innovation Partners?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →